1. A medicament for treating kinetoses, characterized in that is in the form of a pharmaceutical composition comprising the activated and - potentiated form of antibodies to brain-specific proteins and S-100 activated - potentiated form of antibodies to endothelial NO-sintaze.2. A medicament according to claim 1, characterized in that the activated - potentiated form of antibodies to brain-specific proteins and S-100 activated - potentiated form of antibodies to endothelial NO-synthase is used as the activated -potentsirovannogo aqueous or hydroalcoholic solution, which activity is due to the process multiple serial dilution in an aqueous or aqueous-alcoholic solvent with an external mechanical impact - each razvedeniya.3 shaking. A medicament according to claim 1, characterized in that the pharmaceutical composition is made in a solid dosage form contains an effective amount of a neutral carrier granules saturated with water or with a mixture of aqueous-alcoholic solutions of the activated - potentiated form of antibodies to brain-specific proteins and S-100 activated - potentiated antibodies to endothelial NO-synthase, and a pharmaceutically acceptable dobavki.4. A medicament according to claim 2, characterized in that aqueous or hydroalcoholic solutions of activated - potentiated forms of antibodies to brain-specific proteins and S-100 to endothelial N0-synthase obtained by multiple successive dilution in combination with external action - shaking of each dilution matrix solutions of affinity purified1. Лекарственное средство для лечения кинетозов, характеризующееся тем, что выполнено в виде фармацевтической композиции и содержит активированную - потенцированную форму антител к мозгоспецифическому белку S-100 и активированную - потенцированную форму антител к эндотелиальной NO-синтазе.2. Лекарственное средство по п.1, характеризующееся тем, что активированную - потенцированную форму антител к мозгоспецифическому белку S-100 и активированную - потенцированную форм
